Gutierrez S, Parker R, Parker R, Zhang M, Santi M, Ye Y
Mol Pain. 2025; 21:17448069251314738.
PMID: 39921540
PMC: 11898231.
DOI: 10.1177/17448069251314738.
Dubovy P, Hradilova-Svizenska I, Brazda V, Jambrichova A, Svobodova V, Joukal M
Int J Mol Sci. 2025; 26(1.
PMID: 39796050
PMC: 11720091.
DOI: 10.3390/ijms26010193.
Stoian A, Muntean C, Baba D, Manea A, Denes L, Simon-Szabo Z
Int J Mol Sci. 2024; 25(19).
PMID: 39408723
PMC: 11476795.
DOI: 10.3390/ijms251910395.
Abdelaziz M, Chen W, Chang Y, Mindaye S, Chen C
PNAS Nexus. 2024; 3(9):pgae362.
PMID: 39228816
PMC: 11370897.
DOI: 10.1093/pnasnexus/pgae362.
Wu Y, Lin Y, Zhang M, He K, Tian G
Front Neurol. 2024; 15:1380719.
PMID: 39015317
PMC: 11250389.
DOI: 10.3389/fneur.2024.1380719.
A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model.
Bober A, Piotrowska A, Pawlik K, Ciapala K, Maciuszek M, Makuch W
Int J Mol Sci. 2024; 25(13).
PMID: 39000516
PMC: 11242565.
DOI: 10.3390/ijms25137410.
CC Chemokine Family Members' Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury-A Review of Clinical and Experimental Findings.
Ciechanowska A, Mika J
Int J Mol Sci. 2024; 25(7).
PMID: 38612597
PMC: 11011591.
DOI: 10.3390/ijms25073788.
Spinal Cord Stimulation for Intractable Visceral Pain Originating from the Pelvic and Abdominal Region: A Narrative Review on a Possible New Indication for Patients with Therapy-Resistant Pain.
Bieze M, van Haaps A, Kapural L, Li S, Ferguson K, de Vries R
J Pain Res. 2024; 17:691-736.
PMID: 38405684
PMC: 10887953.
DOI: 10.2147/JPR.S445616.
Circulating Inflammatory Biomarkers Predict Pain Change Following Exercise-Induced Shoulder Injury: Findings From the Biopsychosocial Influence on Shoulder Pain Preclinical Trial.
Simon C, Bishop M, Wallace M, Staud R, DelRocco N, Wu S
J Pain. 2023; 24(8):1465-1477.
PMID: 37178095
PMC: 10523877.
DOI: 10.1016/j.jpain.2023.04.001.
Analysis of the Influence of IL-6 and the Activation of the Jak/Stat3 Pathway in Fibromyalgia.
Marino Y, Arangia A, Cordaro M, Siracusa R, DAmico R, Impellizzeri D
Biomedicines. 2023; 11(3).
PMID: 36979771
PMC: 10045851.
DOI: 10.3390/biomedicines11030792.
Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2.
Cho H, Choi Y, Park S, Han Y, Kwon J, Jung S
Int J Mol Sci. 2023; 24(3).
PMID: 36768178
PMC: 9915321.
DOI: 10.3390/ijms24031855.
Intra-amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses.
Wei X, Ma W, Gu H, Liu D, Luo W, Cao S
Cell Prolif. 2022; 56(2):e13354.
PMID: 36266504
PMC: 9890536.
DOI: 10.1111/cpr.13354.
Differences in plasma lipoprotein profiles between patients with chronic peripheral neuropathic pain and healthy controls: an exploratory pilot study.
Jonsson M, Backryd E, Jonasson L, Gerdle B, Ghafouri B
Pain Rep. 2022; 7(5):e1036.
PMID: 36203648
PMC: 9529241.
DOI: 10.1097/PR9.0000000000001036.
Effects of D-Serine and MK-801 on Neuropathic Pain and Functional Recovery in a Rat Model of Spinal Cord Injury.
Yu D, Mun S, Kim S, Cho D, Kim C, Han I
Neurospine. 2022; 19(3):737-747.
PMID: 36203298
PMC: 9537825.
DOI: 10.14245/ns.2244410.205.
Pro-inflammatory cytokines and leukocyte integrins associated with chronic neuropathic pain in traumatic and inflammatory neuropathies: Initial observations and hypotheses.
Dong C, Ubogu E
Front Immunol. 2022; 13:935306.
PMID: 35983047
PMC: 9378781.
DOI: 10.3389/fimmu.2022.935306.
Inhibition of the RNA Regulator HuR by SRI-42127 Attenuates Neuropathic Pain After Nerve Injury Through Suppression of Neuroinflammatory Responses.
Sorge R, Si Y, Norian L, Guha A, Moore G, Nabors L
Neurotherapeutics. 2022; 19(5):1649-1661.
PMID: 35864415
PMC: 9606176.
DOI: 10.1007/s13311-022-01278-9.
Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103.
Ruff M, Inan S, Shi X, Meissler J, Adler M, Eisenstein T
Life Sci. 2022; 306:120788.
PMID: 35817166
PMC: 9398950.
DOI: 10.1016/j.lfs.2022.120788.
Inflammation-Independent Antinociceptive Effects of DF2755A, a CXCR1/2 Selective Inhibitor: A New Potential Therapeutic Treatment for Peripheral Neuropathy Associated to Non-Ulcerative Interstitial Cystitis/Bladder Pain Syndrome.
Brandolini L, Aramini A, Bianchini G, Ruocco A, Bertini R, Novelli R
Front Pharmacol. 2022; 13:854238.
PMID: 35571079
PMC: 9096165.
DOI: 10.3389/fphar.2022.854238.
Mediators of Neuropathic Pain; Focus on Spinal Microglia, CSF-1, BDNF, CCL21, TNF-α, Wnt Ligands, and Interleukin 1β.
Boakye P, Tang S, Smith P
Front Pain Res (Lausanne). 2022; 2:698157.
PMID: 35295524
PMC: 8915739.
DOI: 10.3389/fpain.2021.698157.
The Identification of Blood Biomarkers of Chronic Neuropathic Pain by Comparative Transcriptomics.
Islam B, Stephenson J, Young B, Manca M, Buckley D, Radford H
Neuromolecular Med. 2021; 24(3):320-338.
PMID: 34741226
PMC: 9402512.
DOI: 10.1007/s12017-021-08694-8.